| Dr Jay L Neil Jr, MD | |
|
200 Kennedy Memorial Dr, Waterville, ME 04901-4526 | |
| (207) 944-8815 | |
| Not Available |
| Full Name | Dr Jay L Neil Jr |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 34 Years |
| Location | 200 Kennedy Memorial Dr, Waterville, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770503062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | BN2899980 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Inland Hospital | Waterville, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Maine Healthcare Systems Inland Hospital | 6305817503 | 75 |
News Archive
EKF Diagnostics, today introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer.
Lung cancer is one of the most prevalent types of cancer, with more than 20,000 new cases diagnosed each year in Spain. Lung adenocarcinomas carrying oncogenic KRAS, the engine driving these tumours in 30% of cases, constitute the most aggressive sub-type because, unlike other types of lung cancer, there are no targeted therapies beyond the standard cisplatin-based treatment.
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system.
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
In this post in the Forbes "Leadership" blog, contributor Rahim Kanani interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin about a report titled "Trends in maternal mortality: 1990 to 2010" - released by UNFPA, WHO, UNICEF and the World Bank in May - "which shows that the annual number of women who die in pregnancy or childbirth has dropped from more than 543,000 to 287,000, a decline of 47 percent."
› Verified 5 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
EKF Diagnostics, today introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer.
Lung cancer is one of the most prevalent types of cancer, with more than 20,000 new cases diagnosed each year in Spain. Lung adenocarcinomas carrying oncogenic KRAS, the engine driving these tumours in 30% of cases, constitute the most aggressive sub-type because, unlike other types of lung cancer, there are no targeted therapies beyond the standard cisplatin-based treatment.
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system.
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
In this post in the Forbes "Leadership" blog, contributor Rahim Kanani interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin about a report titled "Trends in maternal mortality: 1990 to 2010" - released by UNFPA, WHO, UNICEF and the World Bank in May - "which shows that the annual number of women who die in pregnancy or childbirth has dropped from more than 543,000 to 287,000, a decline of 47 percent."
› Verified 5 days ago
| Entity Name | Eastern Maine Healthcare Systems Inland Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376579557 PECOS PAC ID: 6305817503 Enrollment ID: O20040802001656 |
News Archive
EKF Diagnostics, today introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer.
Lung cancer is one of the most prevalent types of cancer, with more than 20,000 new cases diagnosed each year in Spain. Lung adenocarcinomas carrying oncogenic KRAS, the engine driving these tumours in 30% of cases, constitute the most aggressive sub-type because, unlike other types of lung cancer, there are no targeted therapies beyond the standard cisplatin-based treatment.
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system.
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
In this post in the Forbes "Leadership" blog, contributor Rahim Kanani interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin about a report titled "Trends in maternal mortality: 1990 to 2010" - released by UNFPA, WHO, UNICEF and the World Bank in May - "which shows that the annual number of women who die in pregnancy or childbirth has dropped from more than 543,000 to 287,000, a decline of 47 percent."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jay L Neil Jr, MD 43 Whiting Hill Rd Ste 300, Brewer, ME 04412-1006 Ph: () - | Dr Jay L Neil Jr, MD 200 Kennedy Memorial Dr, Waterville, ME 04901-4526 Ph: (207) 944-8815 |
News Archive
EKF Diagnostics, today introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer.
Lung cancer is one of the most prevalent types of cancer, with more than 20,000 new cases diagnosed each year in Spain. Lung adenocarcinomas carrying oncogenic KRAS, the engine driving these tumours in 30% of cases, constitute the most aggressive sub-type because, unlike other types of lung cancer, there are no targeted therapies beyond the standard cisplatin-based treatment.
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system.
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
In this post in the Forbes "Leadership" blog, contributor Rahim Kanani interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin about a report titled "Trends in maternal mortality: 1990 to 2010" - released by UNFPA, WHO, UNICEF and the World Bank in May - "which shows that the annual number of women who die in pregnancy or childbirth has dropped from more than 543,000 to 287,000, a decline of 47 percent."
› Verified 5 days ago
Dag Holmsen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 149 North St, Waterville, ME 04901 Phone: 207-622-1959 | |
Michael J Bushey, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 149 North St, Waterville, ME 04901 Phone: 207-872-1270 | |
Carol J Swenson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 149 North St, Waterville, ME 04901 Phone: 207-622-1959 Fax: 207-430-4007 |